Signaturefd LLC Has $334,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Signaturefd LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 4,323 shares of the company’s stock after buying an additional 603 shares during the quarter. Signaturefd LLC’s holdings in GE HealthCare Technologies were worth $334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. First Command Advisory Services Inc. raised its stake in GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares during the last quarter. Fortitude Family Office LLC acquired a new position in GE HealthCare Technologies during the 4th quarter valued at $29,000. Legacy Financial Group LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at $26,000. Turtle Creek Wealth Advisors LLC acquired a new position in GE HealthCare Technologies during the 4th quarter valued at $30,000. Finally, OFI Invest Asset Management acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at $26,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.9 %

GEHC opened at $85.95 on Friday. The firm’s 50-day simple moving average is $88.91 and its 200-day simple moving average is $78.32. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm has a market cap of $39.22 billion, a price-to-earnings ratio of 28.46, a PEG ratio of 3.02 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The company’s revenue was up 5.3% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Mizuho increased their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, April 11th. HSBC assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Citigroup increased their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Argus increased their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Finally, Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.